News and Announcements
Altech Dual Lists On the Frankfurt Stock Exchange
- Published April 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Altech Chemicals Limited (ASX:ATC) is pleased to announce the dual listing of the Company’s shares on the Frankfurt Stock Exchange. The Company’s shares trade under the symbol “A3Y” on the exchange.
KEY TAKEAWAYS:
- Dual listing of Altech shares on Frankfurt Stock Exchange.
- Altech shares trades under the symbol “A3Y”.
- Broadens Altech’s European investor appeal, particularly in Germany.
- Overcomes time zone issues for European retail investors.
The Frankfurt Stock Exchange dual listing supports Altech’s strategy to broaden its European investor base, particularly in Germany where there is growing interest in the Company’s high purity alumina (HPA) project.
As Altech’s shares were already quoted on the Australian Securities Exchange (ASX), a Frankfurt Stock Exchange approved “like” exchange, the dual listing was possible without primary listing procedures such as the filing of a prospectus, consequently the listing was conducted at minimal cost.
The Frankfurt Stock Exchange is the world’s third largest exchange-trading market as measured by trading volume, behind the New York Stock Exchange and NASDAQ. More than 50 percent of the total trades on the Frankfurt Stock Exchange are from investors located in countries outside of Germany.
ltech Chemicals Limited is aiming to become one of the world’s leading suppliers of 99.99% (4N) high purity alumina (HPA) (Al2O3).
HPA is a high-value, high margin and highly demanded product because it is the critical ingredient required for the production of sapphire substrates, which are used in the manufacture of LED lights, alumina semiconductor wafers that are widely used in the electronics industry and for the manufacture of scratch resistant artificial sapphire glass used for watch faces, camera lenses and by various smartphone manufacturers. There is no substitute for HPA in the manufacture of artificial sapphire.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
